Stryker Corporation (SYK)
NYSE
Closed
Aug 24, 2026
Day's Range
327.1052 wk Range
281.00Overview - SYK - Stryker Corporation
Key Statistics
Valuation
Enterprise Value
138.33B
P/E (Trailing)
‪34.13‬
P/E (Forward)
‪19.66‬
PEG Ratio
‪0.79‬
Price / Sales (TTM)
‪4.89‬
Price / Book
‪5.26‬
EV / EBITDA
‪18.75‬
Profitability
Gross Margin
‪68.26%‬
Profit Margin
‪14.43%‬
Operating Margin
‪27.01%‬
Return on Assets
‪8.16%‬
Return on Equity
‪16.50%‬
Ownership
Shares Outstanding
383.57M
Float
347.78M
Short % of Shares Outstanding
‪2.27%‬
Held by Insiders
‪5.36%‬
Held by Institutions
‪82.76%‬
Price stats
Beta
‪0.77‬
50-Day Avg
‪326.60‬
200-Day Avg
‪340.48‬
Dividends
Payout Ratio
‪36.06%‬
Frequency
Quarterly
Analyst Consensus
28 analysts
Average price target
‪$ 382.72‬Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - SYK - Stryker Corporation
Peers - SYK - Stryker Corporation
Peer Comparison
Compared with companies in Medical Devices listed on NYSE.
Profile Summary - SYK - Stryker Corporation
About
Stryker Corporation is a medical technology company that provides products and services designed to improve patient and healthcare outcomes worldwide. It operates primarily through two key segments: MedSurg and Neurotechnology, which encompasses surgical equipment, endoscopic devices, and neurology products; and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
